SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

DISPATCHES FROM BPI EUROPE 2017

CHO stopper? Biogen looks to alternative cell lines for future of bioproduction

Advances in cell line engineering will make hosts such as yeast and algae desirable alternatives to Chinese hamster ovary (CHO) cells in bioproduction, says Biogen.

GSK to ship malaria vaccine for African pilot programme

GSK says maintaining an unbroken cold chain will be critical as it prepares to rollout malaria vaccine pilot programme. 

Daiichi Sankyo pumping $135m into antibody-drug conjugate production

Daiichi Sankyo will plough ‎¥15bn ($135m) into three Japanese manufacturing facilities to support its antibody-drug conjugate pipeline.

PharmaCell to make autologous cell therapies for Lion Biotech

Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.

DISPATCHES FROM BPI EUROPE 2017

Boehringer Ingelheim upping capacity with €700m mammalian cell culture plant

Boehringer Ingelheim has broken ground on a €700m stainless steel bioproduction facility set to house 135,000L of mammalian cell culture capacity.

United BioPharma selects GE Healthcare’s FlexFactory for Taiwan HIV drug plant

United BioPharma Inc. (UBP), with government backing, has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu Industrial Park, Taiwan.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...